Member AUM
$70 trillion
22 September 2021
Key Topic(s)
Animal Welfare
Antibiotics & Health

In this podcast Feeding Resistance Part One, Jo Raven, Senior Manager, Research and Engagements, is joined by Professor Will Gaze from the University of Exeter Medical School and David Tsoupros, Vice President of Senior Research at AllianceBernstein, to discuss what the UN has called the “silent pandemic” within our food system that’s threatening food security, the environment, industries from farming to pharmaceuticals, and global public health.

Antimicrobial resistance, or AMR,  is the emergence of superbugs that are resistant to antibiotics. It is currently responsible for around 700 thousand deaths a year, and the World Bank estimates it could wipe 11% off the world’s GDP by 2050. Animal farming is a key contributor to this crisis, given that an estimated 70% of all antimicrobial use happens within animal agriculture. Without tackling the widespread overuse and misuse of antibiotics in livestock, AMR could become the next global pandemic.

In the first of a two-part series on AMR, this podcast looks at the environmental impacts of this crisis and what investors are doing to address this risk.

FAIRR’s latest report, Feeding Resistance: Antimicrobial stewardship in the animal health industry explores the role of animal pharmaceuticals in driving AMR, and how investors can engage the sector to drive better stewardship.

This podcast is brought to you by the FAIRR Initiative and features members of staff and guest contributors. All such content is intended to contribute to the wider discourse around ESG risks and opportunities in the livestock sector, as well as showcase our research and provide supplementary data and analysis. Please note that our podcasts may present a variety of speakers whose opinions do not necessarily align with the FAIRR Initiative or its board of directors. None of the views expressed should, therefore, constitute financial or other professional advice. If you have any questions or concerns, please contact us at